Procalcitonin and qSOFA as a Marker of Mortality in Sepsis
CONCLUSION: The qSOFA and procalcitonin at presentation to the emergency department in septic patients have a significant correlation with mortality in patients hospitalized with sepsis. Obtaining these two parameters at presentation will help in managing aggressively these patients who at presentation have higher qSOFA and procalcitonin levels.PMID:38644718 | DOI:10.2174/0115748871288534240322083746 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 22, 2024 Category: Cancer & Oncology Authors: Ashaq Hussain Parrey Manzoor Koka Basharat Kasana Mohd Ismail Source Type: research
Procalcitonin and qSOFA as a Marker of Mortality in Sepsis
CONCLUSION: The qSOFA and procalcitonin at presentation to the emergency department in septic patients have a significant correlation with mortality in patients hospitalized with sepsis. Obtaining these two parameters at presentation will help in managing aggressively these patients who at presentation have higher qSOFA and procalcitonin levels.PMID:38644718 | DOI:10.2174/0115748871288534240322083746 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 22, 2024 Category: Cancer & Oncology Authors: Ashaq Hussain Parrey Manzoor Koka Basharat Kasana Mohd Ismail Source Type: research
A Single-group, Clinical Interventional Study on the Effect of Iron Deficiency Anemia on Blood Glucose and Insulin Resistance in Women with Type II Diabetes
CONCLUSIONS: IDA treatment in patients with T2DM can significantly reduce the BG and IR levels. To better control BG, checking iron status and its correction may provide better clinical outcomes in these patients.CLINICAL TRIAL REGISTRATION NUMBER: IRCT20170215032587N3.PMID:38561621 | DOI:10.2174/0115748871297808240308102327 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Mahmoud Parham Gholam Reza Tavasoli Shahram Arsang-Jang Mohamad Amin Habibi Davood Olad Dameshgi Mohammad Reza Pashaei Sajjad Ahmadpour Jamshid Vafaeimanesh Source Type: research
Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience
CONCLUSION: Prolactin-Secreting Pituitary Adenomas (PSPAs) are more common in women than men and are characterized by larger and more invasive tumors with high PRL levels at diagnosis. The PRL level and tumor size before surgery can predict early biochemical remission in both males and females with an accuracy of 58.3% and 68.8%, respectively.PMID:38561622 | DOI:10.2174/0115748871288948240325080936 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Oleksandr Voznyak Iaroslav Zinkevych Andrii Lytvynenko Nazarii Hryniv Roman Ilyuk Nazarii Kobyliak Source Type: research
A Single-group, Clinical Interventional Study on the Effect of Iron Deficiency Anemia on Blood Glucose and Insulin Resistance in Women with Type II Diabetes
CONCLUSIONS: IDA treatment in patients with T2DM can significantly reduce the BG and IR levels. To better control BG, checking iron status and its correction may provide better clinical outcomes in these patients.CLINICAL TRIAL REGISTRATION NUMBER: IRCT20170215032587N3.PMID:38561621 | DOI:10.2174/0115748871297808240308102327 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Mahmoud Parham Gholam Reza Tavasoli Shahram Arsang-Jang Mohamad Amin Habibi Davood Olad Dameshgi Mohammad Reza Pashaei Sajjad Ahmadpour Jamshid Vafaeimanesh Source Type: research
Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience
CONCLUSION: Prolactin-Secreting Pituitary Adenomas (PSPAs) are more common in women than men and are characterized by larger and more invasive tumors with high PRL levels at diagnosis. The PRL level and tumor size before surgery can predict early biochemical remission in both males and females with an accuracy of 58.3% and 68.8%, respectively.PMID:38561622 | DOI:10.2174/0115748871288948240325080936 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Oleksandr Voznyak Iaroslav Zinkevych Andrii Lytvynenko Nazarii Hryniv Roman Ilyuk Nazarii Kobyliak Source Type: research
A Single-group, Clinical Interventional Study on the Effect of Iron Deficiency Anemia on Blood Glucose and Insulin Resistance in Women with Type II Diabetes
CONCLUSIONS: IDA treatment in patients with T2DM can significantly reduce the BG and IR levels. To better control BG, checking iron status and its correction may provide better clinical outcomes in these patients.CLINICAL TRIAL REGISTRATION NUMBER: IRCT20170215032587N3.PMID:38561621 | DOI:10.2174/0115748871297808240308102327 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Mahmoud Parham Gholam Reza Tavasoli Shahram Arsang-Jang Mohamad Amin Habibi Davood Olad Dameshgi Mohammad Reza Pashaei Sajjad Ahmadpour Jamshid Vafaeimanesh Source Type: research
Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience
CONCLUSION: Prolactin-Secreting Pituitary Adenomas (PSPAs) are more common in women than men and are characterized by larger and more invasive tumors with high PRL levels at diagnosis. The PRL level and tumor size before surgery can predict early biochemical remission in both males and females with an accuracy of 58.3% and 68.8%, respectively.PMID:38561622 | DOI:10.2174/0115748871288948240325080936 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Oleksandr Voznyak Iaroslav Zinkevych Andrii Lytvynenko Nazarii Hryniv Roman Ilyuk Nazarii Kobyliak Source Type: research
A Single-group, Clinical Interventional Study on the Effect of Iron Deficiency Anemia on Blood Glucose and Insulin Resistance in Women with Type II Diabetes
CONCLUSIONS: IDA treatment in patients with T2DM can significantly reduce the BG and IR levels. To better control BG, checking iron status and its correction may provide better clinical outcomes in these patients.CLINICAL TRIAL REGISTRATION NUMBER: IRCT20170215032587N3.PMID:38561621 | DOI:10.2174/0115748871297808240308102327 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Mahmoud Parham Gholam Reza Tavasoli Shahram Arsang-Jang Mohamad Amin Habibi Davood Olad Dameshgi Mohammad Reza Pashaei Sajjad Ahmadpour Jamshid Vafaeimanesh Source Type: research
Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience
CONCLUSION: Prolactin-Secreting Pituitary Adenomas (PSPAs) are more common in women than men and are characterized by larger and more invasive tumors with high PRL levels at diagnosis. The PRL level and tumor size before surgery can predict early biochemical remission in both males and females with an accuracy of 58.3% and 68.8%, respectively.PMID:38561622 | DOI:10.2174/0115748871288948240325080936 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Oleksandr Voznyak Iaroslav Zinkevych Andrii Lytvynenko Nazarii Hryniv Roman Ilyuk Nazarii Kobyliak Source Type: research
A Single-group, Clinical Interventional Study on the Effect of Iron Deficiency Anemia on Blood Glucose and Insulin Resistance in Women with Type II Diabetes
CONCLUSIONS: IDA treatment in patients with T2DM can significantly reduce the BG and IR levels. To better control BG, checking iron status and its correction may provide better clinical outcomes in these patients.CLINICAL TRIAL REGISTRATION NUMBER: IRCT20170215032587N3.PMID:38561621 | DOI:10.2174/0115748871297808240308102327 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Mahmoud Parham Gholam Reza Tavasoli Shahram Arsang-Jang Mohamad Amin Habibi Davood Olad Dameshgi Mohammad Reza Pashaei Sajjad Ahmadpour Jamshid Vafaeimanesh Source Type: research
Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience
CONCLUSION: Prolactin-Secreting Pituitary Adenomas (PSPAs) are more common in women than men and are characterized by larger and more invasive tumors with high PRL levels at diagnosis. The PRL level and tumor size before surgery can predict early biochemical remission in both males and females with an accuracy of 58.3% and 68.8%, respectively.PMID:38561622 | DOI:10.2174/0115748871288948240325080936 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Oleksandr Voznyak Iaroslav Zinkevych Andrii Lytvynenko Nazarii Hryniv Roman Ilyuk Nazarii Kobyliak Source Type: research
A Single-group, Clinical Interventional Study on the Effect of Iron Deficiency Anemia on Blood Glucose and Insulin Resistance in Women with Type II Diabetes
CONCLUSIONS: IDA treatment in patients with T2DM can significantly reduce the BG and IR levels. To better control BG, checking iron status and its correction may provide better clinical outcomes in these patients.CLINICAL TRIAL REGISTRATION NUMBER: IRCT20170215032587N3.PMID:38561621 | DOI:10.2174/0115748871297808240308102327 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Mahmoud Parham Gholam Reza Tavasoli Shahram Arsang-Jang Mohamad Amin Habibi Davood Olad Dameshgi Mohammad Reza Pashaei Sajjad Ahmadpour Jamshid Vafaeimanesh Source Type: research
Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience
CONCLUSION: Prolactin-Secreting Pituitary Adenomas (PSPAs) are more common in women than men and are characterized by larger and more invasive tumors with high PRL levels at diagnosis. The PRL level and tumor size before surgery can predict early biochemical remission in both males and females with an accuracy of 58.3% and 68.8%, respectively.PMID:38561622 | DOI:10.2174/0115748871288948240325080936 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Oleksandr Voznyak Iaroslav Zinkevych Andrii Lytvynenko Nazarii Hryniv Roman Ilyuk Nazarii Kobyliak Source Type: research
A Single-group, Clinical Interventional Study on the Effect of Iron Deficiency Anemia on Blood Glucose and Insulin Resistance in Women with Type II Diabetes
CONCLUSIONS: IDA treatment in patients with T2DM can significantly reduce the BG and IR levels. To better control BG, checking iron status and its correction may provide better clinical outcomes in these patients.CLINICAL TRIAL REGISTRATION NUMBER: IRCT20170215032587N3.PMID:38561621 | DOI:10.2174/0115748871297808240308102327 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - April 1, 2024 Category: Cancer & Oncology Authors: Mahmoud Parham Gholam Reza Tavasoli Shahram Arsang-Jang Mohamad Amin Habibi Davood Olad Dameshgi Mohammad Reza Pashaei Sajjad Ahmadpour Jamshid Vafaeimanesh Source Type: research
